Want to see ABCL full AI Analyst Report?
AbCellera Biologics (ABCL) Revenue
AbCellera Biologics Revenue
AbCellera Biologics had a revenue of 4.05M in the quarter ending Jun 30, 2026, with -51.29%. This bring the company's revenue in the last twelve months to 66.17M, Decreased 16.46%. In the fiscal year ending Dec 31, 2025, AbCellera Biologics had annual revenue of 75.13M with 160.56% growth.
- Revenue (ttm)
- 66.17M
- Revenue Growth
- 101.28%
- P/S Ratio
- 52.92
- Revenue/Employee
- $133,680
- Employees
- 562
- Market Cap
- $3.98B
Revenue Chart
AbCellera Biologics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.13M | 46.30M | 160.56% |
| Dec 31, 2024 | 28.83M | -9.19M | -24.17% |
| Dec 31, 2023 | 38.02M | -447.40M | -92.17% |
| Dec 31, 2022 | 485.42M | 110.22M | 29.38% |
| Dec 31, 2021 | 375.20M | 142.05M | 60.92% |
| Dec 31, 2020 | 233.16M | 221.54M | 1907.88% |
| Dec 31, 2019 | 11.61M | 2.78M | 31.49% |
| Dec 31, 2018 | 8.83M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.